| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 12:43:30 UTC |
|---|
| Updated at | 2022-04-28 12:43:30 UTC |
|---|
| NP-MRD ID | NP0067889 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 19'-20'-Epoxyconoduramine |
|---|
| Description | Methyl (1'R,2R,3S,12'R,14'S,18'S)-12'-[(1R,15S,17R,18R)-17-ethyl-6-methoxy-1-(methoxycarbonyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]Nonadeca-2(10),4,6,8-tetraen-7-yl]-3,17'-dimethyl-10',17'-diazaspiro[oxirane-2,15'-tetracyclo[12.3.1.0³,¹¹.0⁴,⁹]Octadecane]-3'(11'),4',6',8'-tetraene-18'-carboxylate belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. 19'-20'-Epoxyconoduramine is found in Tabernaemontana johnstonii (Stapf) Pichon. Based on a literature review very few articles have been published on methyl (1'R,2R,3S,12'R,14'S,18'S)-12'-[(1R,15S,17R,18R)-17-ethyl-6-methoxy-1-(methoxycarbonyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]Nonadeca-2(10),4,6,8-tetraen-7-yl]-3,17'-dimethyl-10',17'-diazaspiro[oxirane-2,15'-tetracyclo[12.3.1.0³,¹¹.0⁴,⁹]Octadecane]-3'(11'),4',6',8'-tetraene-18'-carboxylate. |
|---|
| Structure | CC[C@@H]1C[C@@H]2CN3CCC4=C(NC5=CC(OC)=C(C=C45)[C@H]4C[C@H]5[C@@H]([C@@H](CC6=C4NC4=CC=CC=C64)N(C)C[C@]54O[C@H]4C)C(=O)OC)[C@@](C2)([C@@H]13)C(=O)OC InChI=1S/C43H52N4O6/c1-7-24-14-23-19-42(41(49)52-6)38-26(12-13-47(20-23)39(24)42)27-15-28(35(50-4)18-33(27)45-38)29-16-31-36(40(48)51-5)34(46(3)21-43(31)22(2)53-43)17-30-25-10-8-9-11-32(25)44-37(29)30/h8-11,15,18,22-24,29,31,34,36,39,44-45H,7,12-14,16-17,19-21H2,1-6H3/t22-,23-,24+,29+,31-,34+,36-,39+,42-,43+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Methyl (1'r,2R,3S,12'r,14's,18's)-12'-[(1R,15S,17R,18R)-17-ethyl-6-methoxy-1-(methoxycarbonyl)-3,13-diazapentacyclo[13.3.1.0,.0,.0,]nonadeca-2(10),4,6,8-tetraen-7-yl]-3,17'-dimethyl-10',17'-diazaspiro[oxirane-2,15'-tetracyclo[12.3.1.0,.0,]octadecane]-3'(11'),4',6',8'-tetraene-18'-carboxylic acid | Generator |
|
|---|
| Chemical Formula | C43H52N4O6 |
|---|
| Average Mass | 720.9110 Da |
|---|
| Monoisotopic Mass | 720.38869 Da |
|---|
| IUPAC Name | methyl (1'R,2R,3S,12'R,14'S,18'S)-12'-[(1R,15S,17R,18R)-17-ethyl-6-methoxy-1-(methoxycarbonyl)-3,13-diazapentacyclo[13.3.1.0^{2,10}.0^{4,9}.0^{13,18}]nonadeca-2(10),4,6,8-tetraen-7-yl]-3,17'-dimethyl-10',17'-diazaspiro[oxirane-2,15'-tetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadecane]-3'(11'),4',6',8'-tetraene-18'-carboxylate |
|---|
| Traditional Name | methyl (1'R,2R,3S,12'R,14'S,18'S)-12'-[(1R,15S,17R,18R)-17-ethyl-6-methoxy-1-(methoxycarbonyl)-3,13-diazapentacyclo[13.3.1.0^{2,10}.0^{4,9}.0^{13,18}]nonadeca-2(10),4,6,8-tetraen-7-yl]-3,17'-dimethyl-10',17'-diazaspiro[oxirane-2,15'-tetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadecane]-3'(11'),4',6',8'-tetraene-18'-carboxylate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@@H]1C[C@@H]2CN3CCC4=C(NC5=CC(OC)=C(C=C45)[C@H]4C[C@H]5[C@@H]([C@@H](CC6=C4NC4=CC=CC=C64)N(C)C[C@]54O[C@H]4C)C(=O)OC)[C@@](C2)([C@@H]13)C(=O)OC |
|---|
| InChI Identifier | InChI=1S/C43H52N4O6/c1-7-24-14-23-19-42(41(49)52-6)38-26(12-13-47(20-23)39(24)42)27-15-28(35(50-4)18-33(27)45-38)29-16-31-36(40(48)51-5)34(46(3)21-43(31)22(2)53-43)17-30-25-10-8-9-11-32(25)44-37(29)30/h8-11,15,18,22-24,29,31,34,36,39,44-45H,7,12-14,16-17,19-21H2,1-6H3/t22-,23-,24+,29+,31-,34+,36-,39+,42-,43+/m0/s1 |
|---|
| InChI Key | KFAXDOIQCHDQTO-IRVLEHNQSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Tabernaemontana johnstonii (Stapf) Pichon | Plant | |
|
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Ibogan-type alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Ibogan-type alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Ibogan skeleton
- Vobasan skeleton
- Catharanthine skeleton
- 3-alkylindole
- Pyrroloazepine
- Piperidinecarboxylic acid
- Indole or derivatives
- Indole
- Anisole
- Aralkylamine
- Azepine
- Alkyl aryl ether
- Benzenoid
- Piperidine
- Dicarboxylic acid or derivatives
- Heteroaromatic compound
- Methyl ester
- Pyrrole
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid ester
- Amino acid or derivatives
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Ether
- Oxirane
- Dialkyl ether
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|